Nexome Capital Markets Other Announcement
Nexome Capital Markets filed the CARE Ratings monitoring agency report for the quarter ended 30 Sep 2026 on its Rs. 22.04 crore rights issue. The report shows no deviation from the offer objects.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
21 announcements with these filters
Nexome Capital Markets filed the CARE Ratings monitoring agency report for the quarter ended 30 Sep 2026 on its Rs. 22.04 crore rights issue. The report shows no deviation from the offer objects.
Nexome Capital Markets filed its Reg 10(1A) integrated filing for the quarter ended 30 September 2026, covering financial results, debt default and related-party disclosures. The filing carries auditor reviews and an emphasis of matter on ad hoc provisions against outstanding loans.
Nexome Capital Markets Ltd reported revenue from operations of ₹5.8 Cr (-30.1% YoY) and net profit of ₹0.8 Cr (-20.0% YoY) for Q2 FY27.
NEXOME CAPITAL MARKETS LIMITED has given prior intimation of an Audit Committee meeting on 06 Nov 2026 to consider unaudited standalone and consolidated half-yearly financial results for September 2026. Trading window closes 01 Oct to 16 Nov 2026.
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, in accordance with SEBI Listing Regulations.
Nexome Capital Markets Ltd approved a final dividend of Rs. 1.50 per equity share at its 43rd Annual General Meeting. Payment is scheduled within 30 days.
Nexome Capital Markets Limited held its 43rd Annual General Meeting on August 11, 2026. The company successfully passed all resolutions through voting.
Nexome Capital Markets Limited reported no deviation in the utilization of funds from its previous preferential and rights issues for the quarter ended June 2026. A balance of ₹0.04 Crore remains earmarked for future issue expenses.
Nexome Capital Markets Ltd reported revenue from operations of ₹3 Cr (-82.0% YoY) and net profit of ₹1.2 Cr (-7.7% YoY) for Q1 FY27.
Nexome Capital Markets Ltd scheduled a Board Meeting for August 11, 2026. The meeting will consider the unaudited financial results for the quarter ended June 30, 2026.
Nexome Capital Markets fixed July 31, 2026, as the record date for a Rs. 1.50 per share final dividend. This distribution follows the FY 2025-26 performance.
Nexome Capital Markets released its FY 2025-26 Annual Report. The company scheduled its 43rd Annual General Meeting for August 11, 2026.
Nexome Capital Markets will hold its 43rd Annual General Meeting on August 11, 2026. The meeting will be conducted via video conferencing.
Nexome Capital Markets filed its FY26 Annual Secretarial Compliance Report. The auditor confirmed general regulatory compliance, noting a minor SEBI fine due to clerical errors.
Nexome Capital Markets reported zero deviation in utilizing ₹26.97 Crore raised via preferential and rights issues. Funds were deployed for investments and working capital as planned.
Nexome Capital Markets reported its audited standalone and consolidated financial results for fiscal 2026. The integrated filing provides a comprehensive view of annual performance.
Nexome Capital Markets Ltd reported revenue from operations of ₹21.9 Cr (+121.2% YoY) and net profit of ₹9.4 Cr (+3033.3% YoY) for Q4 FY26.
Nexome Capital Markets reported audited FY26 results and recommended a ₹1.50 per share final dividend. Net profit after tax reached ₹11.57 Crore for the year.
Nexome Capital Markets received BSE trading approval for 19,20,000 equity shares issued via warrant conversion. Trading is effective from May 21, 2026.
Nexome Capital Markets approved its quarterly Monitoring Agency Report for Rights Issue proceeds. The board confirmed compliance and management explanations regarding fund utilization.
Nexome Capital Markets scheduled a board meeting for May 25, 2026, to consider a final dividend. The proposal remains subject to shareholder approval at the AGM.